TLC C-53 liposomal prostaglandin E1: Started 100-patient placebo-controlled Phase II trial. All patients receive tPA, aspirin and heparin, plus a 10-minute infu

The Liposome Co. Inc. (LIPO) Product: TLC C-53 liposomal prostaglandin E1 Indication: Adjunct to tPA in treatment of heart attack Status: Started 100-patient placebo-controlled Phase II trial. All pat...